• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状软骨上部分喉切除术联合环状软骨舌骨会厌固定术治疗声门癌的长期临床疗效

Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.

作者信息

Gong Hongli, Zhou Liang, Wu Haitao, Tao Lei, Chen Xiaoling, Li Xiaoming, Li Cai, Zhou Jian

机构信息

a Shanghai Key Clinical Disciplines of Otorhinolaryngology, Department of Otorhinolaryngology, Eye, Ear, Nose, and Throat Hospital, Fudan University , Shanghai , China.

出版信息

Acta Otolaryngol. 2019 Sep;139(9):803-809. doi: 10.1080/00016489.2019.1616820. Epub 2019 Jun 26.

DOI:10.1080/00016489.2019.1616820
PMID:31240973
Abstract

Laryngeal carcinoma should be treated with the intent of organ-sparing, and supracricoid partial laryngectomy with cricohyoidoepiglottopexy (CHEP) might be an important option. The purpose of this study was to evaluate the clinical outcomes of glottic carcinoma patients treated with CHEP. A series of 164 cases with glottic carcinoma undergoing CHEP from 2006 to 2010 was retrospectively analyzed. The 10-year overall survival (OS) rate, disease-specific survival (DSS) rate, and disease-free survival (DFS) rate were 77.6%, 78.8%, 74.1%, respectively. The OS, DSS, and DFS of patients with stage T1 were higher than patients with stages T2 and T3. Patients with locoregional recurrence and distant metastases had lower OS and DFS than patients with neither recurrence nor metastasis. The DFS of patients with advanced laryngeal carcinoma was worse than that of patients with early-stage carcinoma. T2 and T3 stages, locoregional recurrence, and distant metastases had predictive value regarding patient survival. Additionally, the decannulation rate of postoperative patients was 95.1%, and the nasogastric feeding tube removal rate was 100%. CHEP provided reliable oncologic and functional outcomes, and it should be considered as a standard function-sparing option for glottic T1b, T2, and selected T3 carcinoma patients.

摘要

喉癌的治疗应以保留器官为目的,环状软骨上部分喉切除术联合环舌会厌固定术(CHEP)可能是一个重要的选择。本研究的目的是评估接受CHEP治疗的声门癌患者的临床疗效。回顾性分析了2006年至2010年期间接受CHEP治疗的164例声门癌患者。10年总生存率(OS)、疾病特异性生存率(DSS)和无病生存率(DFS)分别为77.6%、78.8%、74.1%。T1期患者的OS、DSS和DFS高于T2期和T3期患者。发生局部区域复发和远处转移的患者的OS和DFS低于既无复发也无转移的患者。晚期喉癌患者的DFS比早期癌患者差。T2和T3期、局部区域复发和远处转移对患者生存具有预测价值。此外,术后患者的拔管率为95.1%,鼻饲管拔除率为100%。CHEP提供了可靠的肿瘤学和功能学结果,对于声门T1b、T2和部分T3期癌患者,应将其视为一种标准的保留功能的选择。

相似文献

1
Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.环状软骨上部分喉切除术联合环状软骨舌骨会厌固定术治疗声门癌的长期临床疗效
Acta Otolaryngol. 2019 Sep;139(9):803-809. doi: 10.1080/00016489.2019.1616820. Epub 2019 Jun 26.
2
[Long-term efficacy of supracricoid partial laryngectomy for 298 patients with laryngeal carcinoma].[298例喉癌患者行环状软骨上部分喉切除术的长期疗效]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Feb 7;53(2):97-104. doi: 10.3760/cma.j.issn.1673-0860.2018.02.004.
3
Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas.环状软骨上部分喉切除术联合环舌会厌固定术及环舌固定术治疗声门和声门上癌
Laryngoscope. 2000 Apr;110(4):627-34. doi: 10.1097/00005537-200004000-00017.
4
Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.环状软骨上部分喉切除术联合环舌会厌固定术治疗侵犯前联合的“早期”声门型喉癌(T1-T2N0)
Am J Otolaryngol. 1997 Nov-Dec;18(6):385-90. doi: 10.1016/s0196-0709(97)90058-2.
5
Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for recurrent laryngeal cancer.环状软骨上部分喉切除术联合环舌会厌固定术治疗复发性喉癌
Ann Otol Rhinol Laryngol. 2006 Jun;115(6):419-24. doi: 10.1177/000348940611500604.
6
Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience.环状软骨上喉切除术联合环舌骨喉固定术(CHEP)治疗喉癌:肿瘤学结果。35 年经验。
Eur Arch Otorhinolaryngol. 2013 May;270(6):1927-32. doi: 10.1007/s00405-012-2300-4. Epub 2012 Dec 4.
7
Supracricoid partial laryngectomy with crico-hyoido-epiglottopexy for glottic carcinoma with anterior commissure involvement.环状软骨上部分喉切除术联合环甲膜会厌固定术治疗累及前联合的声门癌。
Acta Otorhinolaryngol Ital. 2017 Jun;37(3):188-194. doi: 10.14639/0392-100X-1002.
8
Supracricoid laryngectomy with cricohyoidoepiglottopexy for advanced glottic cancer.环甲膜上喉切除术联合环舌会厌固定术治疗晚期声门癌
Head Neck. 2006 Jun;28(6):481-6. doi: 10.1002/hed.20361.
9
[Supracricoid partial laryngectomy as salvage for recurrent carcinoma of the larynx initially treated by vertical partial hemilaryngectomy. Case report].[环甲膜上部分喉切除术作为初次行垂直部分喉切除术治疗后复发性喉癌的挽救性手术。病例报告]
Cir Cir. 2008 Jul-Aug;76(4):333-7.
10
Supracricoid partial laryngectomy: analyses of oncologic and functional outcomes.环状软骨上喉部分切除术:肿瘤学和功能结果分析。
Otolaryngol Head Neck Surg. 2012 Dec;147(6):1093-8. doi: 10.1177/0194599812457334. Epub 2012 Aug 11.

引用本文的文献

1
Opportunities and limits of open partial horizontal laryngectomies for naïve T3-T4a laryngeal cancer: a systematic review and meta-analysis.初治T3 - T4a期喉癌行开放性部分水平喉切除术的机遇与局限:一项系统评价和荟萃分析
Front Oncol. 2025 Apr 28;15:1550079. doi: 10.3389/fonc.2025.1550079. eCollection 2025.
2
Current Status of Partial Laryngeal Surgery for Advanced Laryngeal Cancer: When and Why?晚期喉癌的部分喉切除术现状:何时及为何?
Curr Oncol Rep. 2024 Jun;26(6):614-624. doi: 10.1007/s11912-024-01516-7. Epub 2024 Apr 22.
3
Oncological Outcomes of Primary vs. Salvage OPHL Type II: A Systematic Review.
原发性与补救性 OPHL Ⅱ型的肿瘤学结局:系统评价。
Int J Environ Res Public Health. 2022 Feb 6;19(3):1837. doi: 10.3390/ijerph19031837.
4
Supracricoid Partial Laryngectomy: Oncological and Functional Outcomes.环状软骨上部分喉切除术:肿瘤学及功能学结果
Int Arch Otorhinolaryngol. 2021 Jul 19;26(1):e075-e084. doi: 10.1055/s-0041-1730020. eCollection 2022 Jan.
5
Oncologic results and quality of life in patients with T3 glottic cancer after transoral laser microsurgery.经口激光显微手术治疗 T3 声门型喉癌的肿瘤学疗效及生活质量评估。
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2983-2992. doi: 10.1007/s00405-020-06445-2. Epub 2021 Jan 6.